Genpax Resources

Genpax CEO Julian Hardy Joins Cycling Challenge from Scotland to Rome for Motor Neuron Disease

Our CEO, Julian Hardy, is currently taking part in the 'All Roads Lead to Rome' cycling challenge in support of the 'My Name'5 Doddie...

Genpax named 2023 winners of the IET Excellence and Innovation Award for Health Technology

Genpax, a life science startup focused on transforming healthcare in detecting, tracing, and mitigating the spread of bacterial...

Genpax Estimates Significant Cost Savings, Health Benefits From WGS Infection Surveillance

NEW YORK – Bioinformatics company Genpax estimates that healthcare systems can save considerable money while preventing infection...

Economic impact of a WGS intervention for HAIs in England and the USA

To access the full paper visit : https://doi.org/10.1099/mgen.0.001087 Abstract Bacterial healthcare-associated infections (HAIs) are a...

Whole Genome Sequencing Can Transform the Management of Healthcare-Associated Infections

A recent economic modelling paper by Genpax, published in Microbial Genomics, concludes that in England, the National Health Service...

SNP-resolution analysis for Listeria monocytogenes

Supplementary Information

Reference-free Whole Genome SNP analysis of Pseudomonas aeruginosa

Supplementary Information

Reference-free WGS SNP-resolution analysis of Campylobacter jejuni

Supplementary Information

A novel genome comparison tool for same-patient samples of E. coli ST131

Supplementary Information

Large-scale hospital outbreak analysis of Klebsiella pneumoniae

Supplementary Information

Novel genome comparison tool for Staphylococcus aureus

Supplementary Information

Genpax attend ASM Microbe 2023 in Houston, Texas.

Genpax attend ASM microbe in Houston from the 15th to the 19th of June, where we present seven posters on our analytical capabilities....

Subscribe to our updates